GlaxoSmithKline Pakistan Income Statement

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65,901	61,188	49,661	41,842	36,661
Revenue Growth (YoY)	7.70%	23.21%	18.69%	14.13%	4.48%
Cost of Revenue	41,618	45,910	46,245	34,505	26,787
Gross Profit	24,283	15,277	3,416	7,336	9,874
Selling, General & Admin	7,283	6,380	6,528	5,139	3,857
Other Operating Expenses	640.12	-1,355	-5,077	-2,871	-856
Operating Expenses	7,924	5,026	1,451	2,268	3,001
Operating Income	16,360	10,252	1,965	5,068	6,873
Interest Expense	-43.12	-19.28	-6.52	-5.37	-5.43
Interest & Investment Income	518.14	538.91	277.02	829.54	374.94
Currency Exchange Gain (Loss)	-51.16	-221.11	68.24	-703.51	-156.49
Other Non Operating Income (Expenses)	-73.27	-72.38	-56.48	-7.37	-2.52
EBT Excluding Unusual Items	16,710	10,478	2,247	5,182	7,084
Merger & Restructuring Charges	-91.29	-5.61	-215.25	-146.51	-321.57
Gain (Loss) on Sale of Assets	74.07	21.88	82.76	124.62	633.9
Asset Writedown	-9.84	-18.39	-6.01	-54.02	-15.54
Other Unusual Items	-	-	68.56	-	43.88
Pretax Income	16,683	10,476	2,177	5,106	7,424
Income Tax Expense	6,658	3,940	1,643	2,643	2,070
Earnings From Continuing Operations	10,025	6,536	533.95	2,463	5,354
Net Income	10,025	6,536	533.95	2,463	5,354
Net Income to Common	10,025	6,536	533.95	2,463	5,354
Net Income Growth	53.39%	1124.09%	-78.32%	-54.00%	58.64%
Shares Outstanding (Basic)	318	318	318	318	318
Shares Outstanding (Diluted)	318	318	318	318	318
EPS (Basic)	31.48	20.52	1.68	7.73	16.81
EPS (Diluted)	31.48	20.52	1.68	7.73	16.81
EPS Growth	53.39%	1124.09%	-78.32%	-54.00%	58.64%
Free Cash Flow	6,081	2,282	234.56	-4,694	3,683
Free Cash Flow Per Share	19.09	7.17	0.74	-14.74	11.57
Dividend Per Share	17.000	10.000	-	-	7.000
Dividend Growth	70.00%	-	-	-	7.69%
Gross Margin	36.85%	24.97%	6.88%	17.53%	26.93%
Operating Margin	24.82%	16.75%	3.96%	12.11%	18.75%
Profit Margin	15.21%	10.68%	1.07%	5.89%	14.61%
Free Cash Flow Margin	9.23%	3.73%	0.47%	-11.22%	10.05%
EBITDA	17,687	11,344	2,881	5,910	7,634
EBITDA Margin	26.84%	18.54%	5.80%	14.12%	20.82%
D&A For EBITDA	1,327	1,093	916.48	841.69	760.47
EBIT	16,360	10,252	1,965	5,068	6,873
EBIT Margin	24.82%	16.75%	3.96%	12.11%	18.75%
Effective Tax Rate	39.91%	37.61%	75.48%	51.76%	27.88%
Advertising Expenses	20.45	24.37	22.89	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.